Cargando…

Does prostate size predict the urodynamic characteristics and clinical outcomes in benign prostate hyperplasia?

AIMS: Bladder outlet obstruction (BOO) in large and small prostates is managed in a similar manner despite considerably different pathophysiology, which can result in higher failure rates. We investigate the clinical and urodynamic features and study the outcome of patients with benign prostate hype...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Kawaljit, Sinha, Rahul Janak, Sokhal, Ashok, Singh, Vishwajeet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532887/ https://www.ncbi.nlm.nih.gov/pubmed/28794586 http://dx.doi.org/10.4103/0974-7796.210029

Ejemplares similares

Transurethral resection of prostate in benign prostatic enlargement with underactive bladder: A retrospective outcome analysis
por: Sokhal, Ashok Kumar, et al.
Publicado: (2017)

Does urodynamics predict voiding after benign prostatic hyperplasia surgery in patients with detrusor underactivity?
por: Thomas, Dominique, et al.
Publicado: (2019)

The influence of preoperative urodynamic parameters on clinical results in patients with benign prostatic hyperplasia after transurethral resection of the prostate
por: Yang, Jiyao, et al.
Publicado: (2023)

Does angiotensin-converting enzyme polymorphism have association with symptomatic benign prostatic hyperplasia?
por: Bid, Hemant Kumar, et al.
Publicado: (2010)

Study of correlation of urodynamic profile with symptom scoring and ultrasonographic parameters in patients with benign prostatic hyperplasia
por: Garg, Ankur, et al.
Publicado: (2020)

Analysis of anastomotic urethroplasty for pelvic fracture urethral distraction defect: Decadal experience from a high-volume tertiary care center
por: Saini, Durgesh Kumar, et al.
Publicado: (2019)

Benign Prostatic Hyperplasia
Publicado: (2015)

Outcomes of transurethral resection and holmium laser enucleation in more than 60 g of prostate: A prospective randomized study
por: Jhanwar, Ankur, et al.
Publicado: (2017)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Clinical Significance of the Resistive Index of Prostatic Blood Flow According to Prostate Size in Benign Prostatic Hyperplasia
por: Kwon, Se Yun, et al.
Publicado: (2016)

Prostatic anatomical parameters correlate with clinical characteristics suggestive of benign prostatic hyperplasia
por: Tian, Ye, et al.
Publicado: (2020)

Urodynamic and continence assessment of orthotropic neobladder reconstruction following radical cystectomy in bladder cancer; a prospective, blinded North Indian tertiary care experience
por: Singh, Vishwajeet, et al.
Publicado: (2014)

Comparative Analysis of the Efficacy and Safety of Photoselective Vaporization of the Prostate for Treatment of Benign Prostatic Hyperplasia according to Prostate Size
por: Park, Ju Hyun, et al.
Publicado: (2010)

Prostatitis and benign prostatic hyperplasia: emerging infectious diseases?
por: Hennenfent, B
Publicado: (1997)

Zinc status in benign prostatic hyperplasia and prostate carcinoma
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)

Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009)

Pathophysiology of clinical benign prostatic hyperplasia
por: Foo, Keong Tatt
Publicado: (2017)

Epidemiology of clinical benign prostatic hyperplasia
por: Lim, Kok Bin
Publicado: (2017)

Botulinum toxin and benign prostatic hyperplasia
por: Ng, Lay Guat
Publicado: (2018)

Solving the benign prostatic hyperplasia puzzle
por: Foo, Keong Tatt
Publicado: (2016)

Tissue microenvironment and benign prostatic hyperplasia
por: Wei, Xing, et al.
Publicado: (2019)

The effect of prostatic inflammation on clinical outcomes in patients with benign prostate hyperplasia
por: Cakir, Suleyman Sami, et al.
Publicado: (2018)

Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk
por: Hung, S-C, et al.
Publicado: (2013)

Current Applications of Artificial Intelligence in Benign Prostatic Hyperplasia
por: Shah, Milap, et al.
Publicado: (2022)

Immunohistochemical analysis of estrogen receptors in prostate and clinical correlation in men with benign prostatic hyperplasia
por: Gangkak, Goto, et al.
Publicado: (2017)

The relationship between glucose homeostasis status and prostate size in aging Chinese males with benign prostatic hyperplasia
por: Wu, Y., et al.
Publicado: (2020)

Zinc status of patients with benign prostatic hyperplasia and prostate carcinoma
por: Christudoss, Pamela, et al.
Publicado: (2011)

Expression and Localization of Aquaporins in Benign Prostate Hyperplasia and Prostate Cancer
por: Hwang, Insang, et al.
Publicado: (2012)

Urinary microbiota in patients with prostate cancer and benign prostatic hyperplasia
por: Yu, Haining, et al.
Publicado: (2015)

Rare Variant of Carcinoma Prostate Masquerading as Benign Prostatic Hyperplasia
por: Khanduri, Sachin, et al.
Publicado: (2019)

Prostate sarcomas: A radiological mimic for benign prostatic hyperplasia
por: Whish-Wilson, Thomas, et al.
Publicado: (2020)

Prostate embolization in the treatment of benign prostatic hyperplasia: what’s the point?
por: Nunes, Thiago Franchi, et al.
Publicado: (2021)

Heat Shock Proteins in Benign Prostatic Hyperplasia and Prostate Cancer
por: Ratajczak, Weronika, et al.
Publicado: (2022)

Shared Inherited Genetics of Benign Prostatic Hyperplasia and Prostate Cancer
por: Glaser, Alexander, et al.
Publicado: (2022)

Anatomical Characteristics and Variants of Prostatic Artery in Patients of Benign Hyperplasia Prostate by Digital Subtraction Angiography
por: Xuan, Hien Nguyen, et al.
Publicado: (2019)

Special emphasis on bone health management in prostate cancer patients: a prospective longitudinal study
por: Sharma, Ashish, et al.
Publicado: (2020)

Linking Pre-Diabetes with Benign Prostate Hyperplasia. IGFBP-3: A Conductor of Benign Prostate Hyperplasia Development Orchestra?
por: Protopsaltis, Ioannis, et al.
Publicado: (2013)

Outcome of Transurethral Plasmakinetic Vaporization for Benign Prostatic Hyperplasia
por: El-Tabey, Magdy, et al.
Publicado: (2015)

Impact of Benign Prostatic Hyperplasia and/or Prostatitis on the Risk of Prostate Cancer in Korean Patients
por: Kim, Sung Han, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0eg8snlhtghvnot618ebp0nako